Baillie Gifford & Co. Reduces Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Baillie Gifford & Co. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 31.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 326,844 shares of the biotechnology company's stock after selling 149,656 shares during the quarter. Baillie Gifford & Co. owned 0.44% of Axon Enterprise worth $84,434,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. ICA Group Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at $25,000. Hollencrest Capital Management acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at $29,000. BKM Wealth Management LLC acquired a new position in Axon Enterprise during the 4th quarter worth about $32,000. First Capital Advisors Group LLC. acquired a new position in Axon Enterprise during the 2nd quarter worth about $33,000. Finally, Tyler Stone Wealth Management acquired a new position in Axon Enterprise during the 2nd quarter worth about $35,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on AXON shares. Argus started coverage on Axon Enterprise in a report on Wednesday, March 13th. They set a "buy" rating and a $380.00 target price on the stock. Needham & Company LLC lifted their target price on Axon Enterprise from $315.00 to $400.00 and gave the stock a "buy" rating in a report on Wednesday. JPMorgan Chase & Co. lifted their price objective on Axon Enterprise from $285.00 to $330.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 28th. JMP Securities lifted their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock a "market outperform" rating in a research report on Tuesday, February 6th. Finally, Morgan Stanley lifted their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $309.45.

Axon Enterprise Stock Up 2.2 %

Axon Enterprise stock traded up $6.99 during midday trading on Wednesday, reaching $318.26. The stock had a trading volume of 502,671 shares, compared to its average volume of 461,660. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The company has a fifty day moving average price of $294.92 and a two-hundred day moving average price of $253.06. The company has a market capitalization of $24.02 billion, a P/E ratio of 138.37 and a beta of 0.93. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $325.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.29. The firm had revenue of $432.14 million during the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. As a group, equities analysts expect that Axon Enterprise, Inc. will post 2.43 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.